Literature DB >> 15832096

Incidental and concurrent malignant lymphomas discovered at the time of prostatectomy and prostate biopsy: a study of 29 cases.

Peiguo G Chu1, Qin Huang, Lawrence M Weiss.   

Abstract

The incidence and histologic features of malignant lymphomas discovered at the time of prostate biopsy, transurethral resection, and prostatectomy are not well documented. We searched our surgical pathology files for malignant lymphomas identified from prostate surgical specimens from 1989 to 2004. Of 4,831 cases of prostate specimens (3,405 biopsies, 266 transurethral resections, 1,160 prostatectomies) examined at the City of Hope during this period, 29 cases of malignant lymphomas involving the prostate and pelvic lymph nodes were identified (0.6%). These malignant lymphomas can be divided into two groups: 1) 18 incidental cases (0.37%) without prior history of malignant lymphoma; and 2) 11 cases (0.23%) with concurrent known malignant lymphoma. For the first group, the patients with pelvic node involvement ranged in age from 59 to 78 years (mean, 69.2 years; median, 70 years), and the patients with prostate involvement ranged in age from 45 to 78 years (mean, 64.6 years; median, 67.5 years). For the second group, the patients ranged in age from 53 to 80 years (mean, 66.8 years; median, 69 years). Diagnoses of all cases were confirmed by immunohistochemistry or molecular analysis. Ten of 18 cases in the first group involved pelvic nodes only, and the other 8 cases were primary prostatic lymphoma. Of 18 cases in the first group, 13 were small lymphocytic lymphoma/chronic lymphocytic leukemia (SLL/CLL), 3 were marginal zone B-cell lymphoma, and 1 was mantle cell lymphoma. These lymphomas were not readily apparent in most cases by histologic examination, and may be confused with chronic prostatitis when the prostate was involved or with reactive lymphoid hyperplasia when pelvic nodes were involved. Immunohistochemistry and molecular studies may be necessary to confirm the diagnosis. For the second group, prostate and pelvic lymph nodes were involved as part of systemic dissemination of concurrent malignant lymphoma. The diagnosis was usually easily established in these cases. Of 11 cases, 4 were SLL/CLL, 4 were follicular lymphoma, 2 were mantle cell lymphoma, and 1 was diffuse large B-cell lymphoma.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15832096     DOI: 10.1097/01.pas.0000153122.65138.b1

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  15 in total

Review 1.  Monoclonal B-cell lymphocytosis and early-stage chronic lymphocytic leukemia: diagnosis, natural history, and risk stratification.

Authors:  Paolo Strati; Tait D Shanafelt
Journal:  Blood       Date:  2015-06-11       Impact factor: 22.113

2.  Unexpected discovery of prostatic diffuse large B-cell lymphoma after thulium laser vaporization in a patient with Waldenstrom macroglobulinemia.

Authors:  Jialei Wang; Huilei Yan; Shuyan Tian; Lei Qin; Yunbo Ma
Journal:  Quant Imaging Med Surg       Date:  2022-01

3.  Successful treatment of concomitant metastatic prostate cancer and B-cell non-Hodgkin's lymphoma with R-EPOCH chemotherapy regimen and antiandrogen therapy.

Authors:  Fayez Hanna; Ajay Prakash; Ebony Allan; Alhossain A Khalafallah
Journal:  BMJ Case Rep       Date:  2018-03-16

4.  Incidental metastatic endocrine tumor diagnosed at laparoscopic radical prostatectomy and bilateral lymph node dissection.

Authors:  Alistair George Rogers; Antony Darné; Naeem A Soomro
Journal:  Indian J Urol       Date:  2012-07

5.  Prolonged survival using anti-CD20 combined chemotherapy in primary prostatic intravascular large B-cell lymphoma.

Authors:  Judit Csomor; Ilona Kaszás; Balázs Kollár; László Pajor; Zsolt Egyházi; Sándor Fekete; Miklós Egyed; Botond Timár
Journal:  Pathol Oncol Res       Date:  2008-05-21       Impact factor: 3.201

6.  Primary prostatic lymphoma with components of both diffuse large B-cell lymphoma (DLBCL) and MALT lymphoma.

Authors:  G Petrakis; T Koletsa; V Karavasilis; G Rallis; M Bobos; G Karkavelas; I Kostopoulos
Journal:  Hippokratia       Date:  2012-01       Impact factor: 0.471

7.  Mantle cell lymphoma of the prostate gland treated with holmium laser enucleation.

Authors:  Preston A Milburn; Christian T Cable; Sean Trevathan; Marawan M El Tayeb
Journal:  Proc (Bayl Univ Med Cent)       Date:  2017-07

8.  Mucosa-associated lymphoid tissue lymphoma and concurrent adenocarcinoma of the prostate.

Authors:  Jung Julie Kang; Michael S Eaton; Yanling Ma; Oscar Streeter; Parvesh Kumar
Journal:  Rare Tumors       Date:  2010-09-30

Review 9.  Incidental advanced-stage Hodgkin lymphoma diagnosed at the time of radical prostatectomy for prostatic cancer: a case report and review of literature.

Authors:  Antonio Di Meglio; Pier Vitale Nuzzo; Francesco Ricci; Bruno Spina; Francesco Boccardo
Journal:  BMC Cancer       Date:  2014-08-26       Impact factor: 4.430

10.  An urologic face of chronic lymphocytic leukemia: sequential prostatic and penis localization.

Authors:  Giovanni D'Arena; Roberto Guariglia; Oreste Villani; Maria Carmen Martorelli; Giuseppe Pietrantuono; Giovanna Mansueto; Giuseppe Patitucci; Emilio Imbriani; Tommaso Masciandaro; Ludovica Borgia; Giulia Vita; Fiorella D'Auria; Teodora Statuto; Pellegrino Musto
Journal:  Mediterr J Hematol Infect Dis       Date:  2013-01-02       Impact factor: 2.576

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.